CLASS ACTION UPDATE for FLKS, HAIR, and GOGO: Levi &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
149
CLASS ACTION UPDATE for FLKS, HAIR, and GOGO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, July 03, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court; further details about the cases can be found at the links provided.

Flex Pharma, Inc. (NASDAQ: FLKS ) Class Period: November 6, 2017 - June 12, 2018 Lead Plaintiff Deadline: August 20, 2018

During the class period, Flex Pharma overstated the viability and approval prospects for its product candidate FLX-787 for the treatment of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease; and as a result, Flex Pharma's public statements were materially false and misleading at all relevant times. On June 13, 2018, Flex announced that it planned to halt its FLX-787 trials, citing oral tolerability concerns observed in both studies. Flex also said that it will restructure its organization to reduce costs, including reducing its workforce by approximately 60%, and that Flex's Board is exploring "strategic alternatives, including the potential sale or merger of the company." Following this news, Flex stock dropped $3.14 per share, or 75.12%, to close at $1.04 on June 13, 2018.

To learn more go to: http://www.zlk.com/pslra-d/flex-pharma-inc?wire=3 .

Restoration Robotics, Inc. (NASDAQGM:HAIR) Class Period: purchases during the Initial public offering commenced on October 12, 2017 and closed on October 16, 2017 Lead Plaintiff Deadline: August 21, 2018

The complaint alleges that Restoration Robotics negligently issued untrue statements of material facts in, and omitted to state material facts required to be stated from, the Offering Materials issued in connection with the Initial Public Offering. The complaint further alleges that as a result of the materially misleading Offering Materials, the Company’s stock price was artificially inflated at the time of the IPO.

To learn more go to: http://www.zlk.com/pslra-d/restoration-robotics-inc?wire=3 .

Gogo Inc. (NASDAQ: GOGO ) Class Period: February 27, 2017 - May 7, 2018 Lead Plaintiff Deadline: August 27, 2018

During the class period, Gogo’s 2Ku antenna had more reliability issues than the public was led to believe;  Gogo’s 2Ku antennas required costly installation and faced costly remediation challenges or required replacement due to deicing fluids from planes infiltrating the 2Ku system, as well as manufacturing and software issues; consequently, Gogo would not be able to meet its previously issued 2018 guidance; and as a result, the company’s financial statements were materially false and misleading at all relevant times.

To learn more go to: http://www.zlk.com/pslra-d/gogo-inc?wire=3 .

You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

CRMLS Partners with Rayse to Enhance Agent-Client Transparency

Updated Category News Views 108

CRMLS Enhances Agent Value with Rayse Platform California Regional MLS (CRMLS), the leading multiple listing service in the nation, has made a significant move by integrating Rayse, a state-of-the-art agent value platform, into its offerings. This collaboration allows all CRMLS agent users to access Rayse at no cost directly through their MLS dashboard, marking a pivotal...

Continue Reading
UMG & TikTok's New Deal: A Boon for Artists?

Updated Category News Views 8

A New Era for Music Collaboration Universal Music Group and TikTok just cranked up the volume on their alliance, announcing a fresh, multi-year licensing agreement. This ain't just another handshake—it signals a seismic shift in how music gets discovered and consumed globally. Strengthened Bonds and Broadened Horizons Under this new agreement, TikTok will offer its...

Continue Reading
How an Investment in Thermo Fisher Scientific Transforms Wealth

Updated Category News Views 425

Unveiling the Growth of Thermo Fisher Scientific Investing is often seen as a pathway to wealth, and for those who placed their trust in Thermo Fisher Scientific Inc. (NYSE: TMO) two decades ago, the rewards have been substantial. This company, which specializes in scientific instrumentation, reagents, and consumables, has consistently outperformed the market. 20 Years of...

Continue Reading
European Energy A/S Launches Tender Offer for Green Bonds

Updated Category News Views 63

European Energy A/S Announces Its Tender Offer European Energy A/S has officially informed the market about a new opportunity for its bondholders. The company is targeting holders of its existing senior unsecured green bonds due in 2025 and 2026, inviting them to tender their bonds as part of a strategic financing move. Tender Offer Details Under this tender offer, which...

Continue Reading
Building a Rehabilitation Hospital: Encompass and BSA Join Forces

Updated Category News Views 170

Encompass Health and BSA Health System Join Forces Encompass Health Corp. and BSA Health System have embarked on a collaborative journey that aims to enhance rehabilitation services for patients recovering from various health challenges. This partnership marks a significant expansion in the healthcare landscape, focusing on providing dedicated rehabilitation care. A...

Continue Reading